Correction: Do hepatic and biliary functional data from gadoxetate-enhanced MRI add value in predicting outcomes in primary sclerosing cholangitis (PSC)? - Takeaways - MDSpire

Correction: Is there added predictive value of hepatic and biliary function data from gadoxetate-enhanced MRI for outcomes in primary sclerosing cholangitis (PSC)?

By
Kumaresan Sandrasegaran
Amar S. Shah
Cole P. Thompson
Channa R. Jayasekera
Elizabeth J. Carey
Ayana Jain
Aubrey N. Silva
Suhaas R. Bonkur
Anshuman J. Panda
Sudhakar K. Venkatesh
Alvin C. Silva
September 30, 2026

European Radiology

Share

1

The article published in European Radiology on 27 June 2026 underwent a name correction.
2

Author Channa R. Jayasekera's name was initially recorded incorrectly.
3

The correction was made to ensure accurate authorship in the publication.
4

The DOI for the corrected article is https://doi.org/10.1007/s00330-026-12710-5.
5

The original article has been revised to reflect this correction.

Original Source(s)

European Radiology

Correction: Do hepatic and biliary functional data from gadoxetate-enhanced MRI add value in predicting outcomes in primary sclerosing cholangitis (PSC)?

by Kumaresan Sandrasegaran, Amar S. Shah, Cole P. Thompson, Channa R. Jayasekera, Elizabeth J. Carey, Ayana Jain, Aubrey N. Silva, Suhaas R. Bonkur, Anshuman J. Panda, Sudhakar K. Venkatesh, Alvin C. Silva
September 30, 2026

Related Content

Food Safety And Risk

Microbiological quality of bread and identification of critical contamination points along the production chain in Ouagadougou, Burkina Faso

Obesity Surgery

Association Between Cholecystectomy and Gastroesophageal Inflammatory Findings After Sleeve Gastrectomy: Endoscopic and Metabolic Evaluation

Journal Of Gastroenterology

Correction: Evaluation of endoscopic submucosal dissection as a treatment option for duodenal tumors ≥ 20 mm: a systematic review and meta-analysis by lesion size